Table 5.
Excess relative risk estimates for all solid cancer mortality by calendar period or age at exposure under linear-quadratic dose-response model: LSS, 1958–2009
| Calendar period | Age at exposure | ||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Year | Deaths | Q/L | P a | Year | Deaths | Q/L | P a |
| 95% CI | 95% CI | ||||||
| Males | Males | ||||||
| 1958–1987 | 3,731 | 0.29b | 0.805 | 20–83 | 4,578 | −0.04 | 0.648 |
| Undefined | −0.35 to 4.53 | ||||||
| 1988–2009 | 3,793 | 5.99 | 0.024 | 0–19 | 2,946 | 7.88 | 0.015 |
| ≤−1.54 or ≥0.18 | NE or ≥0.23 | ||||||
| P c | 0.425 | 0.108 | |||||
| Females | Females | ||||||
| 1958–1987 | 3,885 | 0.22 | 0.643 | 20–83 | 6,010 | 0.28 | 0.583 |
| −0.13 to 1.71 | −0.13 to 3.21 | ||||||
| 1988–2009 | 4,010 | 4.97 | 0.003 | 0–19 | 1,885 | 1.99 | 0.006 |
| ≤−2.31 or ≥0.38 | ≤−4.00 or ≥0.26 | ||||||
| P c | 0.063 | 0.186 | |||||
Note. LSS, Life Span Study. ERR, excess relative risk. L, linear dose coefficient. Q, quadratic dose coefficient. Q/L, ratio of quadratic to linear dose coefficient or curvature. 95% CI, confidence interval. NE, not estimable.
P value for quadratic departure from linearity.
Curvature estimates are from linear-quadratic ERR models with parametric background (common to both calendar periods or ages at exposure), multiplicative adjustment for smoking, independent effect modification by sex, sex-specific attained age, age at exposure, and high dose.
P value for heterogeneity in sex-specific curvature by calendar period or age at exposure.